drugset / Trial / NCT06264635

Evaluating the Efficacy of Platelet-Rich-Plasma (PRP) for Erectile Dysfunction

NCT06264635

Phase 1 Unknown 60 enrolled University of Manitoba
RandomizedParallel-groupDouble-blindTreatment

Summary

There is great interest in restorative therapies (platelet-rich plasma (PRP) injections, shockwave therapy and stem cell therapy) for ED given their non-invasive nature. However, data is still limited and requires further research prior to widespread adoption. Unfortunately, therapies such as PRP injections are being widely used without clinical evidence demonstrating its safety or effectiveness for the treatment of erectile dysfunction. 2-7 To date, there are no treatments that address the underlying cause of endothelial dysfunction, although low-intensity shockwave therapy for ED has shown promising results. Platelet-derived therapies targeting inflammation and promoting tissue/nerve regeneration and may represent a potential treatment option towards this direction. The investigators propose to perform Canada's first pilot RCT to evaluate and safety and efficacy of PRP for the treatment of ED.

Timeline

Start
2025-01-24
Primary completion
2025-03
Completion
2025-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other

Indications